Skip to main content
. 2005 Dec 15;114(5):641–648. doi: 10.1289/ehp.8551

Table 3.

In vivo studies of arsenic exposure and glucose metabolism.

Source Experimental Animal n Compound (route) Daily dose (ppm) Duration Outcomes and results (compared with controls)
Judd 1979 Field mice 19 Methanearsonate (po in water) 1,000 30 days ↓ Blood glucose, = fluid and food consumption
Ghafghazi et al. 1980 Rats 12 Arsenite (ip) 5–10 7 days ↑ Glucose levels after glucose tolerance test, dose dependent
Hughes and Thompson 1996 B6C3F1 mice 72 Arsenate (po in water) 0.025–2.5 28 days ↓ Plasma glucose, = fluid and food consumption
Aguilar et al. 1997 Wistar rats 20 Arsenate (po in food) 5 10 weeks = Plasma glucose levels
Cobo and Castineira 1997 Wistar rats 21 Arsenite (po in water) 17.75 1st week Delayed glucose clearance after glucose tolerance test
up to 100 8th week = Basal insulin levels in vivo
Biswas et al. 2000 Bengal goats 12 Arsenite (po in capsule) 25 12 weeks ↑ Blood glucose at week 6 and ↑↑ at week 12
Arnold et al. 2003 Fischer rats 480 Monomethylarsenic (po in food) 50–1,300 2 years = Blood glucose levels up to 400 ppm, ↓with 1,300 ppm
Pal and Chatterjee 2004a Wistar rats 18 Arsenite (ip) 5.55 21 days ↓ Blood glucose (reversed with methionine)
= Body, liver, kidney weight
Pal and Chatterjee 2004b Wistar rats 18 Arsenite (ip) 5.55 30 days ↓ Blood glucose (reversed with N-acetylcysteine)
Pal and Chatterjee 2005 Wistar rats 18 Arsenite (ip) 5.55 30 days ↓ Blood glucose (reversed with methionine)

Abbreviations: ip, intraperitoneal; po, per oral; ↑, increase; ↓, decrease.